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Abstract
Introduction
Diabetes is a proposed cause of dementia and age-related cognitive decline. While the
effects of hyperglycemia, insulin resistance, and hyperinsulinemia are well-known, scholarship
tends to neglect distinct but related pathologies, such as chronic stress. The purpose of this study
is to evaluate whether a common proxy- mid-life involuntary job loss- is associated with reduced
cognitive function among a cohort of diabetics. A second objective was to determine if age of
diabetes onset moderates this relationship.
Methods
This cross-sectional study gathered diabetes data from the 2003 Health and Retirement
Study (HRS) Mail Survey on Diabetes, while measures of cognitive function (HRS-Cog) and
socio-demographic variables were assessed in the 2002 and 2004 HRS waves. Multivariate
regression was used to analyze the impact of job loss on cognitive function between 1992 and
2002 among 153 job losers and keepers with complete data for employment history, the 35-point
HRS-Cog, age of diagnosis, and glycemic control (HbA1c).
Results
Job losers scored 1.52 points (-3.28-0.24, p<0.09) below keepers in the best fit model,
adjusted for age of onset (<=55, >55) HbA1c quartiles, sex, education, hypertension, and
retinopathy. Age of onset did not moderate the association between job loss and cognitive
function (β = -2.15, CI: -3.89- -0.40; p=0.016); sex, however, was solely responsible for the
reversed, non-significant association in model two (β = -0.37, CI: -2.17-1.43; p=0.687).
Adjustment for all covariates eliminated the significance of the job loss differential, as well as
the effect of onset. Retinopathy, education, and sex remained significant across all adjustments.
Finally, the significance of job loss and onset was independent of each other and their magnitude
comparable across most adjustments.
Discussion
The relationship of involuntary mid-life job loss to cognitive function may reflect the
myriad effects of chronic stress. Even after controlling for well-established predictors of
cognitive decline, the impact of job loss was comparable to the timing of diagnosis. Because the
significance of these two variables, as well as retinopathy, remained when modeled
simultaneously, the effects of stress may involve unique and systemic pathways. Furthermore,
despite strong moderating effects from gender, the magnitude of the coefficient on job loss and
the relatively young cohort are evidence for the hypothesis of premature aging. This study
demonstrates that appropriate interventions may benefit high-risk groups such as those with type
II diabetes and that cortisol could be a viable co-factor related to cognitive function.
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Introduction
A unique set of pathologies links type II diabetes (DM) to dementia and age-related
cognitive decline (ARD). Insulin resistance and hyperglycemia, a common cause of vascular
disease, share the same molecular basis with the formation of the neurotoxic beta-amyloid
protein, and with neurofibrillary tangles, the pathological hallmarks of Alzheimer’s disease (AD)
(Dore et al., 1997; Luchsinger, 2001). The greater hippocampal and cortical atrophy observed in
AD patients with DM compared to non-diabetic age-matched controls, however, was found
independent of vascular disease and glycemic status, suggesting the importance of variations in
insulin resistance (den Heijer et al., 2003). The pro-survival PI3K-PKB insulin signaling
pathway delays neuronal death and, when unresponsive, may accelerate the transport of toxins
across the blood-brain barrier (Cole et al., 2006). Among the pathologies that affect this
pathway, chronic stress is unique, since glucocorticoids also alter the function of monocytes that
inhibit beta-amyloid (Cukierman et al., 2005). The current study, therefore, aims to determine
whether stress is a viable candidate to explain the dramatic course of cognitive decline found in
DM.
Diabetes and Dementia
A disease of impaired glucose metabolism, DM is estimated to increase risk for cognitive
impairment roughly two-fold (Duron & Hanon, 2008). While research supports a generalized
cardiovascular complex, including systolic hypertension, high serum cholesterol, and
atherosclerosis, diabetes is a global epidemic that entails distinct pathology (Korf et al., 2006).
The anticipated “aging of the population” warrants examination of factors such as stress that
potentially change the pathogenic relationship between DM and dementia. Estimates, for
instance, show that the 65 and older U.S. population will have increased from 18 percent in 2000
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to twenty in 2030, and then finally to 1 out of 4 by 2070 (D.R. Williams, 1997). The
consequences of these figures to public health and health care in general are evident: the
prevalence of DM and dementia will increase sharply through late adulthood (NHANES, 2011).
Treatment and care for dementia currently exceeds $600 billion worldwide, or 1 percent of
global gross domestic product. DM prevalence in 2010 was approximately 8 percent in the
general population but 26.9% among those 65 and older- a 100-fold difference compared to the
0.26 percent of those 20 or younger (ADA, 2011)! Importantly, DM could explain a significant
proportion of the expected rise in dementia cases from 40 million today to 115 million by 2050
(ADI, 2010). Therefore, one of the most effective ways to inform national aging policy and
public health preventions is to identify specific DM processes and their relation to ARD.
Diabetes, Stress, and Aging
Though hyperglycemia exposes the brain to higher concentrations of AD-related toxins,
the latter are still found in the brains of middle-aged diabetics who show no signs of cognitive
impairment or neurodegeneration (Li et al., 2005). This limitation is illuminating, since high
blood glucose coincides with elevated levels of neurotoxic proteins and enhanced permeability
within the vasculature itself (Abbott et al., 1990). Moreover, macrovascular (cerebral infarction,
peripheral arterial disease) and microvascular (lacunar infarction, arterioscelerosis) lesion
pathology is associated with amyloid deposition in vivo, as well as with higher rates of oxidative
stress independently of hyperglycemia (Whitehead et al., 2005; Oddo et al., 2003). These
findings imply that a “second hit” may be necessary to induce neurodegeneration and associated
cognitive impairment.
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An alternative explanation for glycemic status and vascular disease is insulin resistance
proper. While glucocorticoids (primarily cortisol) exacerbate the poor use of insulin, a sizeable
number of DM patients may suffer from the withdrawal of cellular signaling that normally
protects neurons from a range of insults (Biessels et al., 2006). Equally important is the
observation that defects to the insulin-mediated pro-survival pathway overlap with the
processing of amyloid-beta and neurofibrillary tangles (Lester-Coll et al., 2006). Though
hyperglycemia and hyperinsulinemia facilitate the movement of these toxins across the brain
parenchyma, extreme insulin resistance may be more detrimental, as growth factor resistance and
plasticity could decline, and protein synthesis accelerate even further (Salkovic-Petrisic, 2006).
Within this causal milieu, cortisol can introduce comparable actions; conversely, cortisol could
interfere with lymphocyte- and monocyte-mediated detoxification (Whitmer, 2007; Sapolsky,
1999). Finally, it is possible for insulin-mediated growth factor production to remain intact, but
for damaged macrophages and Schwann cells to extract insufficient trophic hormone for cellular
regeneration (George et al., 1995; Chaudry & Cornblath, 1992). In other words, the cellular
regenerative process could remain at least partly functional when insulin-related growth factors
do not (Lucas et al., 2001; Stoll & Muller, 1999). Collectively, these outcomes may be more
predictive of memory and learning deficits than the similarly diverse effects of hyperglycemia
and hyperinsulinemia.
In summary, a significant body of evidence justifies the analysis of stress as a unique and
independent etiological agent on the pathway from exposure (DM) to disease (dementia). In
addition, observational and psychological studies note lower working memory scores for DM
patients and for subjects with a self-reported history of distress (Lupien et al., 1998). Despite the
fact that mid-life stress is already a well-established contributor to vascular disease from stroke
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to hypertension- conditions already known to affect cognition- few studies have examined
whether major adverse events interact with critical markers of chronic disease pathology, such as
glycemic control (Hipple, 1999; Turner, 1995; Brenner, 1997; Matoba et al., 2003). As the most
common neurodegenerative disorder, AD is indeed often described as a neuroendocrine disorder,
as well as a disease of impaired clearance (McDonald et al., 2010; Fontbonne et al., 2001).
Stress and Job Loss
The current study uses middle or late life involuntary job loss as a proxy for chronic
stress. This adverse event is a well-established source of chronic psychosocial adversity (Gallo
et al., 2004), and often precedes income, health insurance, and pension severance, as well as
termination of social support in the workplace and uncertainty of reemployment (Chan &
Stevens, 2001; Fallick, 1996). These changes often coincide with lowered perceived behavioral
control (Goodman, 2003) and substance abuse (Price et al., 2000). (The former is associated
with higher cortisol even when controlling for genetic and environmental factors.) Within the
present context, involuntary job loss follows plant, business, or factory closure, and financial or
operational downsizing. Iversen (1989), for instance, found shipyard workers were at higher risk
for cardiovascular hospital admission after their worksite closed. More recently, Gallo &
colleagues (2006) linked late-career job loss with a greater than two-fold increase in both
myocardial infarction (HR: 2.48; 95% CI: 1.49-4.14) and stroke (HR: 2.43; 95% CI: 1.18-4.98).
As several authors note, both the psychological and physical aspects of involuntary job loss
reflect health outcomes associated with chronicity rather than with the buildup of daily hassles or
acute challengers (Kirschbaum & Hellhammer, 1994). These results indicate, at the least, a face
valid proxy.
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The specific objective of this study was to evaluate the association between middle- or
late-life involuntary job loss and performance on a telephone-administered test of cognitive
function among a nationally representative sample of diabetics. The main hypothesis was that
job losers would score significantly lower than keepers. As the most comprehensive populationbased longitudinal study on health and aging in the United States, the Health and Retirement
Study (HRS) is currently the only dataset that samples sufficient numbers of older diabetics, as
well as collects extensive information on employment history, physical health, and cognitive
performance.
A second objective was to test the hypothesis that age of onset moderates the relationship
between employment status and cognitive performance. Specifically, it was speculated that a
variable for the timing of DM diagnosis would capture extreme insulin resistance adequately
enough to reduce the job loss coefficient, and that this effect would exist regardless of glycemic
control. As previously mentioned, research has shown that severe insulin resistance is sufficient
to cause death to a diversity of neurons, and, as importantly, that age of onset may reflect this
pathology even when controlling for DM duration (Falkingham & Namazie, 2002). Recent
studies have also found timing a more significant predictor of cognitive impairment than a
diagnosis alone (Breitling et al., 2012). That is, upon adjustment, differences on COGTEL
scores (an instrument similar to HRS-Cog) virtually disappeared between those with and without
DM.
Methods
Study Design and Data
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This cross-sectional study gathered data for diabetes-related variables from the 2003 HRS
Mail Survey on Diabetes, while scores on the 35-point HRS cognitive measure (HRS-cog) were
collected in 2002 as part of the HRS Cognition Imputations (1992-2008). The Health and
Retirement Study is a nationally representative longitudinal cohort study that samples over
20,000 adults aged 51 years and older biennially. It is administered through the Institute for
Social Research at The University of Michigan and funded federally by the National Institute for
Aging. The objective of the Mail Survey on Diabetes was to gather self-reported questionnaire
data on factors relevant to treatment and self-management, as well as to collect a marker of
glycosylated hemoglobin (HbA1c) for measuring blood glucose control. Study instruments were
validated at the Michigan Diabetes Research and Training Center, while HbA1c was assayed by
Flexisite Diagnostics, Inc. A detailed description of the sampling methodology of both surveys
is available elsewhere (HRS, 2003).
The sample criteria for the current study required that participants meet all of the
following conditions: a self-reported diagnosis of diabetes in the 2002 HRS wave; complete
information from the 2003 HRS Mail Survey on Diabetes for age of diagnosis and HbA1c;
complete data for employment history from 1992 to 2002; and complete scores on the 2002
cognitive assessment from the HRS Cognition Imputations (1992-2008).
A total of 3,194 respondents reported diabetes in the 2002 wave. From this group 2,385
participants were deemed eligible at the start of the 2003 Diabetes Survey, after which 1,901
mail surveys were returned (79.7 % response rate) and used for analysis. Because the 2003
participants were required first to self-report diabetes in 2002, incident cases between
assessments were automatically excluded. This allowed self-reported diabetes to be evaluated as
a precedent of cognitive performance in 2002.
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Access to the 2003 HRS Mail Survey on Diabetes was approved by the Behavioral
Sciences Committee institutional review board at the University of Michigan, while the 2002
HRS wave is available freely to the public. Respondents for both surveys were linked by unique
household and personal identifiers that maintain anonymity.
Primary independent variables
All participants who self-reported diabetes in the 2002 HRS Core and returned the 2003
Survey were eligible for analysis. From the 1,901 participants who returned mail surveys, 1,180
had complete data for age of diagnosis, HbA1c, and employment status. The HRS Core has a
distinct section for job history, including reasons for leaving and changing employers. As a
binary indicator, involuntary job loss was defined as a self-reported plant, factory, or business
layoff between the HRS 1992 baseline and the 2002 follow-up. As the calendar year is not
recorded for job loss prior to 1992, the exclusion of prevalent events effectively reduced the bias
of including those from early and middle adulthood. However, this also resulted in the removal
of potential prevalent late life events among older members of the sample. Since the vast
majority of elders (65+) were retired at baseline, and thus ineligible for analysis, and because the
final sample was limited almost entirely to those who were between 51 and 57 in 1992, this bias
is likely insubstantial.
Participants were considered “exposed” and included in the job loss/stress group had they
reported employment at baseline, followed by job loss at any of the subsequent five waves.
These respondents were also required to have self-reported involuntary job loss at the 2002 HRS
wave, thereby assuring they were truly exposed when the dependent measures were obtained.
The HRS uses a particular question to assess the cause of unemployment among those who cite
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disruption in their work lives: “Did the business close, were you laid off or let go, did you leave
to take care of family members, or what?” The present study distinguished those whose sole
response was “laid off/let go” from those who attested either to voluntary transition (i.e. on
temporary leave, resignation for a better job, retired, etc.) or to departure for medical or personal
reasons (i.e. disability or family crisis). The job loss group further excluded the self-employed
and the re-employed following loss. However, anyone who began working for a new employer
during the 10-year period and who later selected “laid off/let go” was also included.
The comparison group included only respondents employed at baseline and at each
subsequent wave up to 2002. (This was considered an effective way to avoid “the healthy
worker effect.”) The comparison included job changers and those on temporary leave.
Individuals, however, were excluded had they reported retirement, self-employment, or departure
on account of illness or disability, regardless of future job gain. Reporting events before 1992
was also grounds for disqualification. Since access to medical care might have differed across
employer, insurance status at the time of diagnosis and at the 2002 wave was assessed. An
indicator variable was then created comparing those with insurance at both times to those
without.
Although the sample was expected to have varying times of diagnoses (both before and
after the event), limiting the exposed to a single temporal sequence might have produced
insufficient counts. The overwhelming majority (> 90 %), however, reported diagnoses prior to
job loss, thus enabling interpretation of how a significant chronic stressor might alter the vector
of an existing condition of self-reported DM. Because the objective was to evaluate the effects
of a stressful event on the diabetic process in general, self-reporting “laid off/let go” before or
after diagnosis remained the inclusion criterion. Moreover, to differentiate job loss that reflected
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the worsening of chronic disease, participants were excluded if they regarded their illness as a
source of occupational challenge.
Glycemic control was measured with an HbA1c Home Test Kit. Of the 1,901 returned
surveys, a total of 1,233 valid blood samples were obtained, yielding a response rate of 64.9
percent. Quartiles (< 6.3, 6.4-6.9, 7.0-.7.8, > 7.8 mg/dL) were constructed to characterize the
sample’s measurements, where the highest range was associated with hyperglycemia, and the
lowest hypoglycemia.
Model Covariates
Adjustment variables and potential confounders were chosen for their strength of
association with cognitive function in the literature, as well as for their bivariate relationship
within the sample itself. Socio-demographic data was derived from the 2002 HRS and included
age, education, sex, and health insurance. Income was derived from the 2002 Core Income and
Wealth Imputations, and comprised all earnings, including labor and investment income, as well
as pension accrual. The small number of occupation codes rendered the job class distinction
unfeasible. However, prior analysis and imputations with this sample and others show that sex,
net earnings, and education are more significant predictors of test scores (Fisher et al., 2012 ),
while blue-collar occupation in the HRS is relatively low (< 30 %) as a whole (Gallo et. al,
2006). Smoking status (never [ref], former, current) was collected in 2002, as well as the selfreported presence of hypertension, high cholesterol, congestive heart failure (CHF), retinopathy,
and stroke or transient ischemic attack (TIA). Participants were asked specifically, “Has a doctor
ever diagnosed you with [condition]?” Lastly, the Diabetes Survey gathered information on use
of insulin and oral hypoglycemic medication.
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Primary outcome variable
Cognitive function was evaluated on a 35-point scale (HRS-Cog) modeled after the
Telephone Interview for Cognitive Status (TICS), a population-based instrument closely
resembling the Mini-Mental Status Examination (MMSE). The HRS-Cog is part of the HRS
Cognition Imputations (1992-2008), which consist of immediate and delayed recall tests; a
backwards-count from 20 test; a common knowledge test to measure orientation; and a serial-7
subtraction task to measure working memory. Research has shown this test to predict several
outcomes, including greater likelihood of nursing home admission (Banaszak-Holl et al., 2004).
Because these tests were conducted biennially, a sensitivity analysis was also performed with
HRS-Cog data from the 2004 wave. This supplementary analysis was considered appropriate, as
some variables (e.g. HbA1c) were gathered after 2002, even though meaningful change is
unlikely between successive years (Albright et al., 2001).
Data Analysis
The sample is described by means and standard deviations for continuous variables and
frequencies for categorical. Multivariate regression was used to assess the relationship between
job loss and cognitive function. The unadjusted model in Table 3 included the independent
effects of the three primary study variables, including age of diagnosis and HbA1c quartile. The
partially adjusted model 2 was further corrected for age, education, sex, diabetes medication,
income, and insurance. Finally, the fully adjusted model comprised smoking and established
vascular risks, where factors achieving a specified significance (< 0.20) were initially included
but later removed (< 0.15). Variables that altered the coefficient on job loss by greater than 10
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percent were retained in the fully adjusted models from both tables. All analyses were conducted
in SAS 9.2.
Results
Characteristics of the Sample
A total of 1,180 participants had complete information for employment history, age of
onset, and HbA1c levels. Subsequently, forty-one reported work at baseline followed by
involuntary loss and 212 stated continuous employment from 1992-2002. The majority of the
remaining 927 were retired, but a few were disabled, self-employed, or on temporary leave. The
characteristics of the sample are shown in table one. Job losers were slightly older (63.5 v. 61.8,
respectively) than their counterparts at the time of assessment, while both groups were
significantly younger than the diabetic sample as a whole. The comparison group was more
likely to be female (39.7 % v. 23.1 %), to be insured (89.2 % v. 76.3 %), to use oral diabetes
medication (72.2 % v. 51.9 %), and to have hypercholesterolemia (69.6% v. 55.0 %). Job losers
had significantly higher HbA1c readings (7.7 v. 7.2), an earlier age of onset (50.4 v. 52.9), as well
as a higher prevalence of current or former smoking (70.0 % v. 60.7 %). Over half the comparison

group had obtained a college degree or more, while job losers were more likely to have a high
school degree or less (58.6 % v. 50.0 %), even though a greater percentage lay above the $14,250
median for income (53.7 % v. 36.8 %).
From the 253 participants who met the criteria for inclusion into either the job loss group
or the comparison, 153 had complete scores on the HRS-Cog. Five of the 41 job losers and
ninety-five of the controls did not complete the cognitive assessment. The 100 excluded were
more likely to be younger (M = 59.9 + 8.2), to have an earlier age of onset (M = 50.4 + 13.9), and
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to have hypertension (74 %). The five excluded job losers were no more likely than the 95
keepers to have a diagnosis above or below the median (X2 = 0.251, p=0.635).
Association with Cognitive Performance
Job losers scored roughly two points below the comparison in the unadjusted analysis
(22.8 v. 24.9, p <.017). A similar differential surfaced between those diagnosed before and after
age fifty-five (25.5 v. 23.6, p <.014). Neither the scores of the highest HbA1c quartile nor the
intermediary quartiles were significantly better than those of the lowest, while a college degree
or more conferred a clear advantage, as performance was over five points higher compared to
reference (26.2 v. 21.0, p<.001). Higher income (> $14,500) was also beneficial (25.1 v. 23.3, p
<.130), and

females tended to score higher than males (25.5 v. 24.1, p <0.001). Diabetics who had

never smoked (25.6 v. 24.0, p=0.210), and who had hypertension (24.9 v. 23.6, p <.110) or high
cholesterol (24.9 v. 23.8, p <0.200) fared superiorly, though these differences did not reach
significance.
Table 3 shows that job loss ceased to be significant within the partially adjusted model
two. Sex alone accounted for this effect, while education (p<.0001) remained the most significant
predictor. The fully adjusted model three recovered this association moderately (-1.18, p = 0.231),
where changes to the coefficient were most noticeable upon the inclusion of retinopathy (-3.00, p
<0.027).

When HbA1c was added, the lowest quartile (< 6.3) was clearly associated with the

poorest function, whereas the second (6.4-6.9) the highest (1.63, p <0.098).
The best fit models from table 4 indicate that neither onset nor glycemic control
moderated the primary study relationship. In fact, the second model demonstrates that job loss
became more robust (-2.32, p=0.013). The final model relates this loss to a 1.5 point decrement (-
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3.28-0.24, p <0.09), or roughly equivalent to the effect of gender (-1.42, p<0.05). The highest level
of education (5.34, p<0.001) and retinopathy (-2.25, p<0.063) were again the most significant.
When sex was removed, the magnitude of unemployment peaked (-2.71, p<0.003).
Closer analysis revealed no sex difference among the exposed (23.7 v. 23.6, p = 0.990) but
a marginally significant protective effect for females within the comparison (24.5 v. 25.7, p
<.095).

Sensitivity Analysis
Repeated analyses were conducted with data from the HRS 2004 Wave of Cognitive
Imputations. Though the sample size was smaller, scores were still significantly higher (24.8 v.
22.8, p<.056) among job keepers. Age of onset was also a significant determinant of cognition
(24.9 v. 23.1, p<.041), while glycemic control was not (F = 1.13, 3, p=.343). After adjusting for
onset, the association between cognition and job loss declined slightly (-1.62, p=0.136), though
sex again had the largest effect on the coefficient (0.41, p=.843). After controlling for
retinopathy, hypertension, high cholesterol, and smoking, job loss gained predictive power (2.46, p<0.036). Age and education were the only other variables to alter the association
appreciably.
Discussion
To the extent that abrupt and prolonged unemployment captures psychosocial stress, the
current results have several interpretations. A significant stressor was related to poorer cognition
independent of age of onset and a clinical marker of glucose control. This association persisted
after adjustment for hypertension, high cholesterol, and retinopathy, all vascular processes that
overlap with stress. Research often cites delayed recovery from chronic disease, but elevated
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cortisol has several effects: upregulation of pro-inflammatory cytokine signaling; increased
susceptibility to acute infectious illness; and exacerbation of insulin resistance. While this study
is too limited to support a single pathway, the HRS-Cog differential is potentially robust enough
to support the simple notion of a diabetes-stress complex. This conclusion, however, obviously
depends on whether the relatively small study sample captures the characteristics of the
population at-large. If this is the case, the results could reflect what has been described in the
literature as “particular combinations of co-factors that activate different mechanisms of brain
dysfunction and/or neurodegeneration,” as well as “a factor [stress] amplifying the same
mechanism as another already present factor [e.g. insulin resistance] (McDonald et al., 2010).”
In general, elevated cortisol may be one of several conditions that dramatically affect the
pathogenic course of DM.
Compared to diabetes patients stably employed, adult job losers scored roughly two
points less on a validated measure of neuropsychological functioning, a gap that was slightly
above the difference between those with “early” and “late” onset. Interestingly, a recent crosssectional analysis of Germans elders arrived at comparable results (Breitling et al., 2012). In this
work Germans diagnosed with diabetes before the age of 60 scored 2.76 points (-4.64-0.87,
p<.005)

below their counterparts. This differential was later equated to roughly eight years of

excessive aging, and deemed more predictive of cognitive function than a diagnosis alone. The
relatively young sample and limited age range makes it difficult to extrapolate within the present
study; however, previous research has found HRS-Cog quartiles predictive of several adverse
conditions, notably mortality (Mehta et al., 2003). If the job loss differential were influential
enough to displace an observation into an adjacent quartile, our understanding of the burden of
stress could change appreciably. This is a burden that is, of course, associated with early death
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in many studies (Alwin, 2008). Regardless, these results attest strongly to the “premature aging
hypothesis,” since the differential persisted in the presence of a young cohort and the adjustment
for chronic disease.
Models one and two from table 4 imply that age of onset and glucose control might have
been insensitive indexes of abnormality and that they failed collectively to mitigate the effects of
job loss. Diabetes timing, though, was still associated with reduced performance, and its effect
independent of the primary exposure, as well as the demographic factors in model 2 from table
three. While onset was likely too broad to capture disease severity accurately, the interaction of
job loss with DM may have been significant itself. In support of this conclusion, neither
insurance status nor income had discernible impact. Complications arising from inaccessibility
to medical care are therefore unlikely to have contributed meaningfully to the observed
differences.
Greater oxidative stress is one hypothetical effect of stress-induced job loss. Still, this is
an unlikely candidate, since onset and retinopathy were also statistically significant. The
significance of retinopathy, a marker for severe oxidation, does confirm recent work with a
similar age group (Rosebud, 2008), but because the effect of the primary exposure was still
independent of each factor, it is more likely to represent a distinct pathway, such as lowered
synaptic plasticity. Though both stress and retinopathy involve changes to the vasculature, the
former may also elicit cytokines that impair the removal of toxins. As we have seen, AD is often
described as “a disease of impaired clearance.”
Within the context of statistical modeling, crude distinctions such as time of onset and
self-reported retinopathy (without regard to duration) may be too general to moderate the
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systemic and manifold effects of stress. The contributions of cortisol to brain function and
memory impairment may also differ by time of onset within the stage of disease. It may, for
instance, play an important role in the early stages of ARD, particularly since amyloid
accumulation, at its extreme, is unlikely to result from insulin resistance alone (Stewart &
Liolitsa, 1999). Future work should integrate descriptive clinical and epidemiological data to
determine whether one pathway most strongly modifies the effect of proxies like job loss,
leading to what appears here to be “advanced cognitive aging.”
In the current analysis, the relationship among stress, diabetes, and cognitive aging
depends on how one interprets the role of gender, which single-handedly reversed the primary
coefficient. This association effectively vanished, and the hypothesis that time of onset would
moderate the relationship between stress and cognition nullified. Interestingly, female sex was
associated with higher performance among job keepers but not losers. This finding belies what
would otherwise be a tempting interpretation: current research shows that females tend to adapt
differently- and more effectively- to adverse major life events (Belle, 1987). Female sex in this
sample, however, may reflect occupational variation, differential exposure to complex tasks, or
simple biological difference. If being female was related to less work strain, greater job
complexity, or more autonomy within the workplace, selection bias could result. (Obviously,
bias could have existed differentially between losers and keepers.) Thus the absence of relevant
data on occupation and rank is the single most serious flaw that limits the generalizability of
these results. On the other hand, research with the same cohort has found sex, rather than job
class, a protective influence on the incidence of both cerebrovascular disease and lacunar
infarction (Gallo et al., 2004). Future studies should also assess the prevalence and trajectory of
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workplace learning and the performance of complex tasks, as well as how they impact each
gender.
This is the first epidemiological evaluation of emerging laboratory and clinical evidence
for the pathogenic role of chronic stress on diabetes-related cognitive function. Strengths of the
analysis include the use of a wide range of physiological measurements, the inclusion of a
nationally representative sample of adult diabetics, and a relatively long period of observation
(1992-2002). While past studies have assessed the joint effect of blood cortisol levels and
chronic disease, the current incorporated detailed data on many of the most relevant markers. In
addition, nearly all job losers were diagnosed before the event and excluded had they reported
DM to have a negative career effects. The removal of prevalent events at baseline eliminated the
bias of including those from middle and early adulthood. Lastly, the diversity of adjustment
variables was comparable to past studies (Allen et al., 2004).
Several limitations deserve notice. The aforementioned failure to characterize the nature
of both the workplace and the transitional environment was the most critical, even though prior
studies differentiated only between blue- and white-collar occupations, and were less likely to
incorporate characteristics relevant to the outcome (Gallo et al., 2000). Secondly, recent HRS
work has found lower cognitive scores among workers who retire early in life but also
acknowledges that poor cognition leads to retirement (Rohwedder & Willis, 2010). The
potential for “reverse causality” is considerable, and controlling for this effect is challenging
within the HRS. Unlike most studies, however, age was insignificant. This anomaly may reflect
the younger sample age (compared to the entire HRS diabetes cohort) and the limited age range,
as well as the exclusion of retirees. The small percentage of nona- and octogenarians could have
placed a ceiling on the significance of several exposures, notably onset and stroke. Likewise, the
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cognitive effects of an adverse midlife event could be insubstantial to older elders compared to
the cumulative effects of chronic disease. The prevalence of cerebrovascular disease was also
relatively small for an adult sample of diabetics, and the low number of job losers was not
representative of a group generally regarded at the very highest risk for ARD. Finally, several
variables would likely improve the best fit model from table 4 (adjusted-R2 = 0.317), including
the duration and treatment of retinopathy, the nature of post-work social support, and the
genotyping of APOE 4, the only known genetic risk factor for late-onset sporadic AD.
The consequences of stress to brain structure and function are not transient. Involuntary
job loss shares characteristics with the most harmful stressors, specifically those that are novel,
unpredictable, and uncontrollable. Even though most societies have provisions for population
change, these measures are undermined by recessions, mass layoffs, and financial hardship. The
risk of chronic disease is also greater for the roughly 2 million unemployed Americans over the
age of fifty-five, a group that not only requires the longest time to regain employment but that
expends greater energy to acquire the same set of skills (Rich, 2010). Even though prevention
commonly addresses ARD, few concern the stress response following a major event. Recent
research has even shown that high school students diagnosed with the disease are 10 percent less
likely to find employment and can expect to lose an average of $160,000 in lifetime earnings
(Fletcher & Richards, 2012). It would not be surprising then for a diabetes-stress complex to
gain even greater attention in the subsequent years.
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List of Tables
Table 1. Description of the Eligible Sample by Involuntary Job Loss (n = 1,180)
All Diabetics
Job Loss
Non-Job Loss
Characteristic
N (%)*
N (%)*
N (%)*
Age (years), mean + SD
Sex
Male
Female
Education
Less than high School
High School
Some college
College or more
Age of onset (years), mean + SD
HbA1c, mean + SD
Insurance
Yes
No
Income

> 14,250 (US $)
< 14,250 (US $)
Insulin use
Yes
No
Oral diabetes medication use
Yes
No
Smoking history
Never
Former
Current
Stroke or transient ischemic attack
Yes
No
Hypertension
Yes
No
High Cholesterol
Yes
No
Retinopathy
Yes
No
Congestive Heart Failure
Yes
No

68.6 + 8.7

63.5 + 7.8

61.8 + 6.9

330 (28.0)
289 (24.5)

20 (48.7)
6 (14.6)

73 (34.4)
48 (22.6)

354 (30.0)
402 (34.1)
213 (18.1)
211 (17.9)
57.6 + 13.5
7.2 + 1.4

10 (24.4)
14 (34.2)
11 (26.8)
6 (14.6)
50.4 + 13.8
7.7 + 1.4

40 (18.9)
66 (31.1)
44 (20.8)
62 (29.3)
52.9 + 11.9
7.2 + 1.5

986 (83.6)
146 (12.4)

29 (70.7)
9 (21.9)

181 (85.4)
22 (10.4)

316 (26.8)

22 (53.7)

78 (36.8)

864 (73.2)

19 (46.3)

134 (63.2)

273 (23.1)
879 (74.5)

9 (22.0)
32 (78.0)

40 (18.9)
170 (80.2)

854 (72.4)
291 (24.7)

31 (51.9)
10 (48.1)

148 (70.0)
57 (26.9)

234 (19.8)
259 (22.0)
134 (11.4)

9 (22.0)
12 (29.3)
9 (22.0)

48 (22.6)
51 (24.1)
23 (10.8)

64 (5.4)
1,073 (90.9)

0 (0.0)
40 (97.6)

5 (2.4)
204 (96.2)

869 (73.6)
284 (24.1)

27 (65.9)
14 (34.1)

145 (68.4)
60 (28.3)

711 (60.3)
420 (35.6)

22 (53.7)
18 (43.9)

142 (67.0)
62 (29.2)

155 (13.1)
964 (81.7)

5 (12.2)
32 (78.0)

20 (9.4)
182 (85.8)

138 (11.7)
999 (84.7)

3 (7.3)
37(90.2)

7 (3.3)
202 (95.3)

* Numbers may not sum to 1,180 due to missing data, and percentages may not sum to 100% due to missing data.
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Table 2. Mean (95 % confidence intervals) HRS-Cog Scores for Keepers and Losers by Study Characteristic (n = 153)

Characteristic
Job Loss
Yes
No
Age of onset (years)
< 55
>55
HbA1c (quartiles)
< 6.3
6.4-6.9
7.0-7.8
> 7.8
Age
51-59
60-69
70+
Sex
Male
Female
Education
Less than high School
High School
Some college
College or more
Income (US $)
> 14,250
< 14,250
Insulin use
Yes
No
Oral diabetes medication use
Yes
No
Smoking history
Never
Former
Current
Hypertension
Yes
No
High Cholesterol
Yes
No
Retinopathy
Yes
No

N*

Total Score

p†
<0.017

36
117

22.8 (20.4-25.1)
24.9 (24.2-25.6)

84
69

23.6 (22.4-24.8)
25.5 (24.7-26.3)

38
44
35
36

24.0
25.3
24.2
24.1

<0.014

<0.540

(22.8-25.1)
(24.0-26.7)
(22.7-25.7)
(21.9-26.3)

23
110
20

23.4 (20.1-26.7)
25.0 (24.2-25.8)
22.5 (21.0-24.0)

88
53

24.1 (23.5-25.3)
25.5 (24.3-26.7)

37
50
30
36

21.0
24.7
26.2
26.2

96
57

25.1 (24.2-26.0)
23.3 (21.9-24.6)

26
127

25.2 (23.7-26.7)
24.3 (23.4-25.1)

115
36

24.6 (23.6-25.5)
24.1 (22.8-25.4)

54
61
30

25.6 (24.5-26.8)
24.5 (23.6-25.5)
24.0 (21.9-26.1)

98
51

24.9 (24.0-25.9)
23.6 (22.1-25.1)

96
51

24.9 (23.9-25.8)
23.8 (22.4-25.2)

<0.200

13
133

23.7 (20.7-26.6)
24.6 (23.8-25.4)

<0.520

<0.052

0.127
<0.001

(19.6-22.4)
(23.3-26.0)
(24.5-27.9)
(24.8-27.5)
0.021

0.351

<0.650

0.210

<0.110

* Numbers may not sum to 153 due to missing data.
†
P-value is for pooled equality of variances test (continuous variable).
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Table 3. Multiple linear regression models predicting total HRS-Cog scores by 3 primary study variables (n = 153)
Model 1a
Predictor
Involuntary Job Loss
No
Yes
Age of onset (years)
> 55
< 55
HbA1c (quartiles)
< 6.3
6.4-6.9

7.0-7.8
> 7.8
a

Model 2b

Unadjusted β
(95 % Confidence Interval)

p

Reference
-2.16 (-3.93- -0.39)

---

Reference
-1.91 (-3.42-0.40)
Reference
1.34 (0.08-2.29)
0.23 (0.05-2.58)
0.08 (-1.98-0.29)

0.017

--0.014

--0.207
0.841
0.942

Adjusted β
(95 % Confidence Interval)
Reference
-0.37 (-2.17-1.43)

Model 3c
p

--0.687

Reference
-1.39 (-2.89-0.10)

--0.067

Reference
1.23 (-0.62-3.08)
1.05 (-0.94-3.02)
1.05 (-1.02-3.13)

0.191
0.298
0.317

---

Adjusted β
p
(95 % Confidence Interval)
Reference
-1.18 (-3.12-0.76)

0.231

Reference
-0.88 (-2.51-0.76)

0.290

Reference
1.54 (-0.40-3.49)
1.08 (-0.96-3.11)
1.71 (-0.53-3.96)

0.118
0.297
0.138

Unadjusted with individual effects of the three predictors.
Adjusted for age, sex, education, income, insurance, insulin, and oral diabetes medication.
c
Adjusted for age, sex, education, income, insurance, insulin, oral diabetes medication, smoking history (never, former, current),
hypertension, high cholesterol, and retinopathy.
b

---

---

---
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Table 4. Best fit multiple linear regression models predicting total HRS-Cog scores by involuntary job loss (n = 153)
Model 1a
Predictor
Involuntary Job Loss
No
Yes
a

Model 2b

Adjusted β
(95 % Confidence Interval)

p

Reference
-2.15 (-3.89- -0.40)

--0.016

Adjusted β
(95 % Confidence Interval)
Reference
-2.32 (-4.15- -0.49)

Model 3c R2 = 0.317
p

--0.013

Adjusted β
p
(95 % Confidence Interval)
Reference
-1.52 (-3.28- 0. 24)

Adjusted for age of onset.
Adjusted for age of onset and HbA1c quartiles.
c
Best fit model. Adjusted for age of onset, HbA1c quartiles, sex, education, hypertension and retinopathy.
b

--<0.09
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